MENU
+Compare
CMPX
Stock ticker: NASDAQ
AS OF
Apr 28 closing price
Price
$1.90
Change
-$0.04 (-2.06%)
Capitalization
262.74M

CMPX Compass Therapeutics Forecast, Technical & Fundamental Analysis

Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies... Show more

CMPX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for CMPX with price predictions
Apr 28, 2025

CMPX's RSI Indicator recovers from oversold territory

The RSI Oscillator for CMPX moved out of oversold territory on April 07, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 38 similar instances when the indicator left oversold territory. In of the 38 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on April 16, 2025. You may want to consider a long position or call options on CMPX as a result. In of 69 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for CMPX just turned positive on April 14, 2025. Looking at past instances where CMPX's MACD turned positive, the stock continued to rise in of 42 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CMPX advanced for three days, in of 179 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 40 cases where CMPX's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CMPX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

CMPX broke above its upper Bollinger Band on April 22, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for CMPX entered a downward trend on April 10, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CMPX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.098) is normal, around the industry mean (14.339). P/E Ratio (0.000) is within average values for comparable stocks, (64.948). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.831). Dividend Yield (0.000) settles around the average of (0.023) among similar stocks. P/S Ratio (303.030) is also within normal values, averaging (255.967).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CMPX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
CMPX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

CMPX is expected to report earnings to -10 cents per share on May 12

Compass Therapeutics CMPX Stock Earnings Reports
Q1'25
Est.
$-0.11
Q4'24
Missed
by $0.01
Q3'24
Beat
by $0.03
Q2'24
Est.
$-0.10
Q1'24
Beat
by $0.03
The last earnings report on February 28 showed earnings per share of -10 cents, missing the estimate of -10 cents. With 553.49K shares outstanding, the current market capitalization sits at 262.74M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
80 Guest Street
Phone
+1 617 500-8099
Employees
32
Web
https://www.compasstherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ENHNX10.070.03
+0.30%
Cullen Enhanced Equity Income I
NMIEX11.75N/A
N/A
Northern Active M International Equity
OMSYX26.35N/A
N/A
Invesco Main Street All Cap Y
ATHGX25.63N/A
N/A
American Century Heritage R5
AFOCX21.90N/A
N/A
Archer Focus

CMPX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CMPX has been loosely correlated with VCYT. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if CMPX jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CMPX
1D Price
Change %
CMPX100%
-8.49%
VCYT - CMPX
37%
Loosely correlated
+0.28%
FHTX - CMPX
36%
Loosely correlated
-2.46%
SANA - CMPX
35%
Loosely correlated
N/A
VIR - CMPX
34%
Loosely correlated
-2.70%
ARVN - CMPX
33%
Loosely correlated
-0.98%
More